Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation

This pilot study will try to demonstrate metabolic changes in spine lesions treated by Augmentation and Ablation, according to existing standards of practice. Our purpose is to show the efficacy of a new radiofrequency ablation (RFA) in combination with augmentation, using a percutaneous ablation device (Osteocool-Medtronic) in the treatment of secondary vertebral bone tumor, avoiding concurrent bias related to other treatments of the disease.

NCT Number	NCT06716294
Lead Sponsor	National and Kapodistrian University of Athens
Conditions	Bone Cancer Metastatic, Radiofrequency Ablation, Spine Metastases, Vertebral Metastasis
Enrollment	16 participants
Start Date	2023-01-01
Primary Completion	2028-06-01 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-09